Relationships Between Physical Activity and Inhibitory Control Among College Students

June 19, 2024 updated by: Liye Zou, Shenzhen University

Relationships Between Physical Activity and Inhibitory Control Among College Students: fNIRS and Fundus Imaging

The primary aim of this study is to explore the impact of a 20-minute aerobic exercise on inhibitory control, microvascular diameters, and brain function. The main questions it aims to answer are:

  1. Is there a correlation among the level of physical activity, performance in inhibitory control, and the diameter of retinal microvasculature, and do retinal microcirculation parameters mediate this relationship?
  2. Does short-term aerobic exercise (moderate and high intensity) improve inhibitory control and physiological markers, such as retinal diameter and frontal brain activation, compared to a sedentary control group?

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • China
    • Guangdong
      • Shenzhen, Guangdong, China
        • Body-Brain-Mind Laboratory, School of Psychology, Shenzhen University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • right-handed (how was handedness assessed; i.e., "What hand do you write with?") with normal or corrected-to-normal vision and normal color vision

Exclusion Criteria:

  • reported a history of cardiovascular, metabolic, gastrointestinal, neurological, or psychiatric disorders, medical conditions requiring medical care, substance addiction, strict diets (e.g., low- carbohydrate and Mediterranean diet), pregnancy, or lactation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Moderate-intensity cycling
Moderate-intensity cycling on Ergoline Ergoselect 100
Behavioral: Moderate-intensity cycling
Moderate-intensity cycling on Ergoline Ergoselect 100
Behavioral: Uninterrupted sitting
Uninterrupted sitting in a quiet room
Experimental: Vigorous-intensity cycling
Vigorous-intensity cycling on Ergoline Ergoselect 100
Behavioral: Uninterrupted sitting
Uninterrupted sitting in a quiet room
Behavioral: Vigorous-intensity cycling
Vigorous-intensity cycling on Ergoline Ergoselect 100
Experimental: Uninterrupted sitting
Uninterrupted sitting in a quiet room
Behavioral: Uninterrupted sitting
Uninterrupted sitting in a quiet room

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognitive function
Time Frame: 21 weeks
This primary outcome measure is assessed by the modified dual-task Stroop paradigm.
21 weeks
Retinal Vessel Diameter
Time Frame: 21 weeks
Retinal Vessel Diameter is assessed by the fully automated fundus camera.
21 weeks
Brain Connectivity
Time Frame: 21 weeks
Brain connectivity is assessed by the NIRSport2 device
21 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Shenzhen University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2024

Primary Completion (Estimated)

January 1, 2025

Study Completion (Estimated)

February 1, 2025

Study Registration Dates

First Submitted

June 19, 2024

First Submitted That Met QC Criteria

June 19, 2024

First Posted (Actual)

June 25, 2024

Study Record Updates

Last Update Posted (Actual)

June 25, 2024

Last Update Submitted That Met QC Criteria

June 19, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • SZUPaIntervention

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognition

Clinical Trials on Moderate-intensity cycling

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe